Cyproheptadine Hydrochloride

盐酸赛庚啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCyproheptadine Hydrochloride
Drug Alias Name二苯环庚啶cyproheptadinum盐酸塞庚啶cyproheptadineciproheptadina +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine receptor antagonists
TargetsHistamine receptor
Therapy Area/IndicationsSolid tumoursAbdominal PainBody Weight Changes +[14] 
Global Approved IndicationsUrticariaPruritusEczema +[5] 
Approved Indications in ChinaUrticariaPruritusEczema
Original Approved Country/TerritoryUnited States
Original Approved Date1961/10/17
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesRevue Juridique Des Etudiants Et Etudiantes De L'Universite Laval IncChangzhou Siyao Pharmaceuticals Co Ltd
Inactive CompaniesUniversity Of South FloridaUniversity Of MichiganMerck & Co Inc
Active IndicationsUrticariaPruritusEczema +[4] 
Inactive IndicationsSolid tumoursAbdominal PainBody Weight Changes +[10] 

Other Information

ATC CodeR06AX02
Related LinksWikipediaDrugBankKEGG